Financiers with a great deal of cash to invest have actually taken a bearish position on Praxis Accuracy Medication (NASDAQ: PRAX).
And retail traders need to understand.
We discovered this today when the exhibition up on openly offered choices history that we track here at Benzinga.
Whether these are organizations or simply rich people, we do not understand. However when something this huge occurs with PRAX, it typically indicates someone understands something will take place.
So how do we understand what these financiers simply did?
Today, Benzinga’s choices scanner found 21 unusual choices trades for Praxis Accuracy Medication.
This isn’t regular.
The total belief of these big-money traders is divided in between 38% bullish and 47%, bearish.
Out of all of the unique choices we discovered, 11 are puts, for an overall quantity of $481,965, and 10 are calls, for an overall quantity of $1,290,815.
Anticipated Rate Variety
Considering the Volume and Open Interest on these agreements, it appears that whales have actually been targeting a rate variety from $65.0 to $300.0 for Praxis Accuracy Medication over the last 3 months.
Examining Volume & & Open Interest
Analyzing the volume and open interest supplies important insights into stock research study. This info is type in assessing liquidity and interest levels for Praxis Accuracy Medication’s choices at particular strike rates. Listed below, we provide a picture of the patterns in volume and open interest for calls and puts throughout Praxis Accuracy Medication’s considerable trades, within a strike cost series of $65.0 to $300.0, over the previous month.
Praxis Accuracy Medication 30-Day Choice Volume & & Interest Photo
Most Significant Options Found:
| Sign | PUT/CALL | Trade Type | Belief | Exp. Date | Ask | Quote | Rate | Strike Rate | Overall Trade Rate | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PRAX | CALL | SWEEP | BULLISH | 02/20/26 | $ 210.0 | $ 207.0 | $ 210.0 | $ 65.00 | $ 420.0 K | 633 | 40 |
| PRAX | CALL | SWEEP | BULLISH | 02/20/26 | $ 205.0 | $ 201.5 | $ 205.0 | $ 65.00 | $ 389.5 K | 633 | 0 |
| PRAX | CALL | TRADE | BULLISH | 05/15/26 | $ 85.0 | $ 80.6 | $ 84.05 | $ 230.00 | $ 168.1 K | 6 | 20 |
| PRAX | PUT | TRADE | BEARISH | 12/19/25 | $ 15.0 | $ 13.0 | $ 15.0 | $ 250.00 | $ 75.0 K | 0 | 559 |
| PRAX | PUT | SWEEP | BULLISH | 02/20/26 | $ 8.5 | $ 3.6 | $ 3.6 | $ 150.00 | $ 73.4 K | 200 | 200 |
About Praxis Accuracy Medication
Praxis Accuracy Medicines Inc is a clinical-stage biopharmaceutical business. The company is taken part in equating hereditary insights into the advancement of treatments for clients impacted by main nerve system conditions defined by a neuronal excitation-inhibition imbalance. The business has actually produced 3 clinical-stage item prospects, ulixacaltamide (previously called PRAX-944), vormatrigine (previously called PRAX-628), and relutrigine (previously called PRAX-562), in addition to PRAX-020 which has actually been in-licensed by UCB Biopharma SRL, or UCB.
After an extensive evaluation of the choices trading surrounding Praxis Accuracy Medication, we transfer to analyze the business in more information. This consists of an evaluation of its existing market status and efficiency.
Praxis Accuracy Medication’s Current Market Status
- Trading volume stands at 2,383,909, with PRAX’s cost up by 29.72%, placed at $246.44.
- RSI indications reveal the stock to be might be overbought.
- Incomes statement anticipated in 84 days.
What The Professionals State On Praxis Accuracy Medication
In the last month, 5 professionals launched rankings on this stock with a typical target cost of $203.2.
Unusual Options Activity Detected: Smart Cash on the Move
Benzinga Edge’s Unusual Options board areas prospective market movers before they take place. See what positions huge cash is handling your preferred stocks. Click on this link for gain access to
* Constant in their examination, an expert from HC Wainwright & & Co. keeps a Buy ranking on Praxis Accuracy Medication with a target cost of $340.
* In a mindful relocation, an expert from HC Wainwright & & Co. reduced its ranking to Purchase, setting a rate target of $258.
* An expert from Wedbush has actually chosen to keep their Underperform ranking on Praxis Accuracy Medication, which presently sits at a rate target of $83.
* An expert from HC Wainwright & & Co. has actually chosen to keep their Buy ranking on Praxis Accuracy Medication, which presently sits at a rate target of $258.
* Preserving their position, an expert from Wedbush continues to hold a Underperform ranking for Praxis Accuracy Medication, targeting a rate of $77.
Trading choices includes higher threats however likewise uses the capacity for greater revenues. Smart traders reduce these threats through continuous education, tactical trade modifications, using numerous indications, and remaining attuned to market characteristics. Stay up to date with the most recent choices trades for Praxis Accuracy Medication with Benzinga Pro for real-time notifies.